机构:[1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China河北医科大学第四医院医技科室临床科室医技科室科研中心医技科室[2]Tumor Research Institute, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China河北医科大学第四医院[3]Oncology Department, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China河北医科大学第四医院血液内科临床科室[4]Breast Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China河北医科大学第四医院外一科临床科室[5]Research Center, the Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, People's Republic of China[6]Radiotherapy Department, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China河北医科大学第四医院胸部放疗一病区临床科室
Aims: The LIM domain only proteins (LMOs) which consist of four members (LMO1-LMO4) are a family of nuclear transcription coregulators that are characterized by the exclusive presence of two tandem LIM domains and no other functional domains. They regulate gene transcription by functioning as "linker" or "scaffolding" proteins by virtue of their LIM domains and are involved in the formation of multiprotein complexes with several DNA-binding factors and transcriptional regulatory proteins. In the present study, we tried to find the physical interaction between p53 and LMO4, and the effect of LMO4 on p53-mediated proliferative inhibition of breast cancer cells. Main methods: FCM analysis was developed to detect the apoptosis of breast cancer cells after adriamycin (ADR) treatment. RT-PCR and Western blot analysis were performed to detect the expression of LMO4 and p53-related genes and proteins. Immunoprecipitation assay was used to detect the interaction between LMO4 and p53. Colony formation assay was developed to detect the proliferation of breast cancer cells. Key findings: We found that p53 was induced, but LMO4 was down-regulated in response to ADR. We also found that enforced expression of p53 inhibited the expression of LMO4, suggesting that LMO4 is a direct transcriptional target of p53. Furthermore, LMO4 can interact with p53 and inhibit p53-mediated inhibition of colony formation of breast cancer MDA-MB-453 cells. Significance: The present study showed that LMO4 is a direct target of p53 and inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53. (C) 2012 Elsevier Inc. All rights reserved.
基金:
National Nature Science Foundation
of China (no. 81001178).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2012]版:
大类|3 区医学
小类|3 区医学:研究与实验3 区药学
最新[2025]版:
大类|3 区医学
小类|2 区药学3 区医学:研究与实验
JCR分区:
出版当年[2012]版:
Q2MEDICINE, RESEARCH & EXPERIMENTALQ2PHARMACOLOGY & PHARMACY
最新[2024]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China
通讯作者:
通讯机构:[1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China[2]Tumor Research Institute, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China[*1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050017, People's Republic of China
推荐引用方式(GB/T 7714):
Zhou Xinliang,Sang Meixiang,Liu Wei,et al.LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53[J].LIFE SCIENCES.2012,91(9-10):358-363.doi:10.1016/j.lfs.2012.08.005.
APA:
Zhou, Xinliang,Sang, Meixiang,Liu, Wei,Gao, Wei,Xing, Enhong...&Shan, Baoen.(2012).LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.LIFE SCIENCES,91,(9-10)
MLA:
Zhou, Xinliang,et al."LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53".LIFE SCIENCES 91..9-10(2012):358-363